Ranbaxy ‘mitigates market pressures’

Ranbaxy has mitigated the market pressures it faces as a result of the ongoing global economic downturn, it has been asserted.

Atul Sobti, chief executive and managing director at the firm, made the comments as the organisation delivered its financial results for the second quarter and first half of its financial year, which ended June 30th.

For the second quarter, the firm posted consolidated net sales of $368 million (223.1 million pounds). Meanwhile, for the first half of the year, it reported net sales of $682 million.

Mr Sobti, who has held the positions since May, said that the global economy has faced a range of challenges over the last few months and both liquidity and demand have been affected by these obstacles.

“Our balanced market mix with a clear focus on emerging markets has helped us mitigate these pressures. We have improved operationally over the last quarter despite ongoing challenges,” he added.